Biotech's Samantha Du Ready For Next Stage [Forbes]
Zai Lab Limited - American Depositary Shares (ZLAB)
US:NASDAQ Investor Relations:
zailaboratory.com/about/investors.php
Company Research
Source: Forbes
Samantha Du, founder and CEO of Zai Lab. Just 4 years after its founding, her billion-dollar firm Zai Lab is about to commercialize a cancer drug. Zai Lab When Samantha Du left Chi-Med to head healthcare investments at Sequoia China in 2011, she thought she’d retire there. Then in 2014, she did the opposite: at 49 years old, the mother of two left to become an entrepreneur again. Her change of heart gave birth to Zai Lab, the Shanghai-based biotech company that made a high-profile debut on Nasdaq in 2017 with a $1.4 billion market cap. When the firm raised another $150 million in a secondary offering on Nasdaq this fall, it was still not generating any revenue. But that’s about to change. In October, Zejula (niraparib), a cancer drug Zai developed in partnership with Tesaro, received approval in Hong Kong for the maintenance treatment of ovarian cancer. The product’s official launch is scheduled for next Tuesday. In the four years since Zai’s founding,
Show less
Read more
Impact Snapshot
Event Time:
ZLAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZLAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZLAB alerts
High impacting Zai Lab Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ZLAB
News
- A Risky Bet: Zai Lab's Uncertain Future [Seeking Alpha]Seeking Alpha
- Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024Business Wire
- Zai Lab Statement on Executive Management Team's Agreement on Share Activities [Yahoo! Finance]Yahoo! Finance
- Zai Lab Statement on Executive Management Team’s Agreement on Share ActivitiesBusiness Wire
- Zai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology Programs [Yahoo! Finance]Yahoo! Finance
ZLAB
Earnings
- 11/7/23 - Beat
ZLAB
Sec Filings
- 4/19/24 - Form S-3ASR
- 4/19/24 - Form PRE
- 4/5/24 - Form 4
- ZLAB's page on the SEC website